Fast Five Quiz: Glycemic Control in Type 2 Diabetes

Romesh Khardori, MD, PhD


February 21, 2023

One of the key treatment goals of type 2 diabetes treatment is to reduce the risk for microvascular complications, such as retinopathy, neuropathy, and kidney diseases, through glycemic and blood pressure control. The UK Prospective Diabetes Study demonstrated that every 1% decrease in A1c was associated with improved long-term outcomes and that a sustained period of glycemic control reduced the risk for microvascular disease in patients with newly diagnosed type 2 diabetes. When implemented early in the course of disease, achieving A1c targets of < 7% has been shown to reduce microvascular complications.

Other goals are to reduce the risk for macrovascular complications, such as coronary, cerebrovascular, and peripheral vascular disease, through control of lipids and blood pressure, as well as through smoking cessation; and to reduce the risk for metabolic and neurologic complications through glycemic control.

Learn more about the goals of type 2 diabetes treatment.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.